{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040757","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.382846+00:00","generated_at":"2026-05-30T16:30:54.516493+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cocrystal Pharma ratifies exec salary hikes to $416K, $200K bonuses, and RSU grants","bullets":["James Martin (CFO/co-CEO) and Dr. Sam Lee (President/co-CEO) base salary increased from $400K to $416K, plus $200K bonus and 40,000 RSUs each.","Non-employee director grants: Dr. Kornberg $60.5K cash + $100K SAB stipend + 28,109 RSUs; Dr. Frost $44,770 + 27,100 RSUs; Steven Rubin $82,280 + 18,957 RSUs.","Other director grants: Fred Hassan $36,300 + 8,067 RSUs; Richard Pfenniger $36,300 + 8,067 RSUs; Dr. Japour $54,450 + 14,924 RSUs.","Half of each RSU grant vested immediately; remaining half vests quarterly over two years starting Sep 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040757","json":"https://secwatch.observer/filing/0001493152-24-040757.json","markdown":"https://secwatch.observer/filing/0001493152-24-040757.md","text":"https://secwatch.observer/filing/0001493152-24-040757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/0001493152-24-040757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:30:54.516493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}